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Innate immunity provides essential protection against life-threatening
fungal infections. However, the outcomes of individual skirmishes be-
tween immune cells and fungal pathogens are not a foregone conclu-
sion because some pathogens have evolved mechanisms to evade
phagocytic recognition, engulfment, and killing. For example, Candida
albicans can escape phagocytosis by activating cellular morphogenesis
to form lengthy hyphae that are challenging to engulf. Through live
imaging of C. albicans–macrophage interactions, we discovered that
macrophages can counteract this by folding fungal hyphae. The fold-
ing of fungal hyphae is promoted by Dectin-1, β2-integrin, VASP,
actin–myosin polymerization, and cell motility. Folding facilitates the
complete engulfment of long hyphae in some cases and it inhibits
hyphal growth, presumably tipping the balance toward successful
fungal clearance.
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An estimated 1.5 million people succumb to a systemic fungalinfection each year (1). Most of these individuals had HIV
or had undergone a medical intervention that severely compro-
mised their immunity. The innate immune system plays a key
role in preventing fungal infection (2–4). The efficacy of these
defenses depends on the outcome of individual interactions be-
tween innate immune cells and fungal pathogens.
Innate immune cells such as macrophages recognize fungal
pathogens via pattern recognition receptors (PRRs) that interact
with pathogen-associated molecular patterns (PAMPs), many of
which lie at the fungal cell surface (5, 6). The formation of a
phagocytic synapse between PRRs and PAMPs triggers the ac-
tive engulfment of the pathogen and subsequent attempts to kill
the fungal cell using a variety of mechanisms that include a toxic
mix of reactive chemical species and antimicrobial peptides (2).
Meanwhile, fungal pathogens attempt to evade immune recog-
nition, phagocytosis, and killing through a range of strategies
that include PAMP masking to reduce recognition (7, 8), robust
stress responses to attenuate the potency of reactive oxygen and
nitrogen species (9–11), the activation of pyroptosis to kill the
immune cells (12–14), and in particular, cellular morphogenesis
(15–18). Candida albicans activates morphogenetic programs to
form hyphae that are challenging to phagocytose and clear, not
least because of their extreme length (6, 15, 16). Hypha forma-
tion also provides a means of fungal escape from the macro-
phage (12, 13).
While examining dynamic interactions between macrophages
and fungal cells, we observed that these immune cells can fold
fungal hyphae. We reasoned that this fungal folding must involve
the application of mechanical forces and that this folding contrib-
utes to fungal clearance. Therefore, we examined the involvement
of the cytoskeletal network and PRRs in this phenomenon, pro-
viding initial clues as to how macrophages anchor a fungal hypha
and achieve leverage to fold it.
Results
Macrophages Can Fold Fungal Hyphae. To monitor the dynamic
interactions between fungal and innate immune cells we per-
formed live imaging of macrophage cultures inoculated with live
yeast cells of the wild-type C. albicans clinical isolate SC5314.
Cell wall stains such as Calcofluor White perturb cell wall
PAMPs (19, 20) and, thereby, immune interactions, and there-
fore we avoided such stains. As reported previously (15, 16),
some yeast cells formed hyphae in response to the culture con-
ditions or following phagocytosis, yielding morphologically di-
verse fungal populations. Interestingly, we found that some long
hyphae were folded by the macrophages, often at fungal septal
junctions, a known point of fragility (21) (Fig. 1A and Movies
S1–S5). Innate immune cells have been reported to exert force at
the cell surface in the act of phagocytosing C. albicans yeast cells
(22). This suggests that immune cells continue to exert force
following the phagocytic engulfment of fungal hyphae.
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As mentioned, C. albicans cells display considerable morpho-
logical heterogeneity during live cell imaging of macrophage–fungus
interactions. Therefore, we used a morphogenetically locked mu-
tant to facilitate quantification of fungal folding. C. albicans tup1Δ
cells lack Tup1, a transcriptional repressor of hyphal development
(23). Consequently, they constitutively form long, nonaggregating
pseudohyphal filaments. These tup1Δ filaments were phagocytosed,
but direct comparisons of phagocytosis efficiencies for lengthy
tup1Δ filaments and wild-type hyphae were not feasible because the
wild-type hyphae aggregated to form clumps. Significantly, murine
bone marrow–derived macrophages (BMDMs) folded these tup1Δ
filaments, some of which were over 100 μm in length (Movie S6).
Some filaments were folded multiple times (Fig. 1B and Movie
S7). The ability of macrophages to fold fixed, nongrowing hyphae
(Movies S6 and S7) clearly distinguishes this phenomenon from
that of thigmotropism, which involves contact sensing and re-
sponses to mechanical forces during the polarized growth of
hyphae (24–26).
To explore the generality of hyphal folding, we examined dif-
ferent types of macrophage. We observed folding of C. albicans
hyphae by BMDMs, thioglycolate-elicited peritoneal macrophages
(thio-macs), macrophage cell lines (J774.1 and RAW 264.7 cells),
and human monocyte–derived macrophages. Furthermore, we
found that BMDMs were capable of phagocytosing and folding
hyphae of the evolutionarily divergent nonsporulating mold, My-
celia sterilia (Movie S8).
Folding Damages Fungi.We predicted that folding might damage the
hypha. To test this, we examined points of fungal folding in more
detail, observing indentations at septal fold sites (Fig. 1A) and, in
some cases, breakage of fixed hyphae during folding (Movie S9).
Imaging of cell wall components by immunofluorescence revealed
significant disruption of cell wall architecture at these fracture sites.
Chitin and β-glucan are normally located in the inner layer of the C.
albicans cell wall (27, 28). However, staining of engulfed, live, folded
hyphae with wheat germ agglutinin and Fc-Dectin-1 showed that
chitin and β-glucan, respectively, became more exposed at fracture
sites compared with unfolded septal junctions (Fig. 1C). Both chitin
and β-glucan are immunomodulatory PAMPs (5, 29–31) that are
normally covered by the mannan in the outer layer of the C. albi-
cans cell wall (32). Therefore, folding disrupts the cell wall archi-
tecture of C. albicans hyphae to affect PAMP exposure.
Hyphal growth slows following internalization by macrophages
(33). To test whether fungal folding exacerbates this growth in-
hibition, we performed live imaging of macrophages phagocytos-
ing growing wild-type C. albicans cells. We measured the extension
rates of individual hyphae over an hour-long period. Internalized
hyphae, whether folded or not, were impaired in their growth
compared with hyphae that had not been engulfed (Fig. 1D), as
reported previously (33). Comparing internalized hyphae, the
folded hyphae displayed significantly reduced extension rates
compared with nonfolded hyphae. Therefore, mechanical folding
retards fungal growth. In the context of antifungal immunity, this
presumably promotes fungal clearance by reducing the escape of
cargo from the macrophage.
Folding Requires Actin and Myosin II. Actin forms dynamic struc-
tures around phagosomes containing C. albicans hyphae (16, 34).
Therefore, we tested whether actin contributes to fungal folding.
Using SiRActin (a silicon-rhodamine-based acting binding fluo-
rophore) to monitor actin dynamics in macrophages, we ob-
served that dynamic actin rings formed around tup1Δ hyphae,
particularly around their septa (Movie S10). This was confirmed
by rhodamine phalloidin staining of macrophages interacting
with tup1Δ and wild-type cells (Fig. 2A). Some actin rings were
located at hyphal folds (Fig. 2A).
We investigated whether actin functionality is required for hyphal
folding. Actin inhibition blocks phagocytosis (35–37), and therefore
to permit initial phagocytosis, macrophages were allowed to interact
with tup1Δ filaments for 1.5 h before cytoskeletal inhibitors were
added. C. albicans–macrophage dynamics were then imaged at
1 min intervals for a further 2 h, and the folding of internalized
hyphae was categorized and quantified: none (no detectable bend-
ing or folding); moderate (creating a curved hypha or an obtuse
angle), or high (generating an acute angle). Macrophages treated
with the F-actin–binding reagent, cytochalasin D, were unable to
fold their hyphal cargo, whereas those treated with carrier alone bent
or folded around 35% of internalized hyphae (Fig. 2B). Similarly,
macrophages exposed to the actin monomer–binding inhibitor
Fig. 1. Physical manipulation and damage of C. albicans hyphae by mac-
rophages. (A) Live C. albicans SC5314 cells were added to cultures of mac-
rophages (multiplicity of infection 3:1): (i) BMDM, (ii) thio-macs, (iii) J774.1,
(iv) RAW264.7, and (v) human monocyte–derived macrophages for up to 6 h
of live-cell imaging. Selected movie frames show phagocytosed hyphae
folding at sites indicated with arrows. Movies of fungal folding can be
viewed in Movies S1–S5. (B) Selected frames from live-imaging movies
showing longer fixed C. albicans tup1Δ hyphae being folded, thereby fa-
cilitating complete engulfment of the long particle. The arrows highlight
two folding events on the same hypha. The corresponding movie can be
viewed in Movie S6. (C) Live C. albicans SC5314 cells were allowed to interact
with thio-macs for 4 h and then fixed. Exposure of cell wall mannan (ConA,
red), β-glucan (Fc-Dectin-1, green), and chitin (WGA, blue) was examined. A
representative three-dimensional (3-D) image reconstruction (3-D opacity) of
a phagocytosed filament is shown, revealing fracture at the folded septal
junction (white arrows). Partially or unfolded septal junctions are also
highlighted (black arrows). (D) Human monocyte–derived macrophages
were combined with live C. albicans SC5314 cells and their interactions im-
aged for 6 h. Movies were analyzed for phagocytic events and hyphal
growth, and the Volocity line tool used to measure hyphal length and cal-
culate growth rate (micrometers per minute). Hyphae were categorized
according to whether they were internalized and folded, internalized but
not folded, or not phagocytosed (external): n = 24 to 43 events per category.
Statistical differences between groups were determined by ANOVA with
Tukey’s multiple comparison test, post hoc; *P < 0.05, ***P < 0.001.
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latrunculin A were unable to fold hyphae (Fig. 2C). Therefore, actin
functionality is essential for hyphal folding.
Myosin II contributes to the formation of actomyosin bundles
capable of generating mechanical tension within mammalian
cells (38–40). Therefore, we tested whether myosin II contributes
to hyphal folding by pretreating macrophages with the inhibitor
blebbistatin for 2 h before exposure to tup1Δ hyphae. Blebbis-
tatin did not affect phagocytosis significantly (SI Appendix, Fig.
S1A). However, blebbistatin-treated macrophages displayed sig-
nificantly reduced folding compared with control macrophages
treated with carrier alone (Fig. 2D). We conclude that macro-
phages also require myosin II to fold hyphae.
The mechanical delivery of cargo into target cells by cytotoxic T
lymphocytes involves actin polarization and microtubule networks
at the immunological synapse (41, 42). Therefore, we tested
whether microtubules promote hyphal folding by treating macro-
phages with colchicine, a microtubule inhibitor. The phagocytosis
of tup1Δ hyphae was unaffected by colchicine (SI Appendix, Fig.
S1B), and significantly, fungal folding was not impaired (Fig. 2E),
suggesting that microtubules are not required for hyphal folding.
PAMP–PRR Synapses Promote Folding. How does a macrophage
grasp a fungal hypha in order to fold it? We reasoned that
PAMP–PRR synapses provide a potential means of physically
connecting a hypha to the cytoskeleton across the phagosomal
membrane. The C-type lectin, Dectin-1, plays a key role in fungal
recognition and phagocytosis by interacting with β-glucan exposed
at the fungal cell surface (5, 29, 30). Furthermore, Dectin-1 has
been reported to potentiate the formation of intense actin cuffs
around phagosomes that are attempting to engulf fungal hyphae
(33). Therefore, we tested whether this PRR also plays a role in
hyphal folding by comparing macrophages from Dectin-1−/−
knockout and wild-type mice. Our live imaging confirmed previous
reports (43, 44) that Dectin-1 inactivation reduces the ability of
macrophages to phagocytose C. albicans cells. In our hands, the
Dectin-1−/− macrophages phagocytosed fixed tup1Δ hyphae at
28% of the wild-type rate. Those Dectin-1−/− macrophages that
did successfully engulf a hypha displayed significantly reduced
frequencies of hyphal folding (Fig. 3A). Furthermore, this folding
was less severe (i.e., fewer hypha were folded at an acute angle).
We repeated the experiment with serum-opsonized hyphae,
which enhanced phagocytosis by the Dectin-1−/− macrophages to
47% of the wild-type rate. Again, Dectin-1−/− macrophages were
less able to fold their hyphal cargo than control wild-type macro-
phages (Fig. 3B). We then tested the effects of pretreatment with
laminarin, a soluble beta-glucan that blocks Dectin-1 (45, 46).
Laminarin pretreatment reduced but did not completely block the
Fig. 2. Role of cytoskeleton in hyphal folding. (A) BMDMs (MV) were mixed
with fixed C. albicans tup1Δ hyphae (Left) or live C. albicans SC5314 yeast
cells (Right) stained with Calcofluor White (CFW, blue). Dynamic changes in
actin localization were monitored by time-lapse fluorescence microscopy
using rhodamine phalloidin staining (red). Dynamic patterns of actin pat-
terns, including rings and punctate structures, were associated with C.
albicans–containing phagosomes. Representative images at 120 or 180 min
are shown. (B) Pretreatment of BMDMs with the actin inhibitor cytochalasin
D (5 μM) blocks fungal folding, unlike the carrier, DMSO. Folding of pre-
internalized hyphae was quantified by scoring unfolded cells (gray), hyphae
displaying moderate bending (obtuse angle; pale green), and hyphae dis-
playing strong folding (acute angle; dark green). (C) The actin inhibitor
latrunculin A (1 μM) inhibits fungal folding; carrier, DMSO. (D) The myosin II
inhibitor blebbistatin (20 μM) inhibits fungal folding; carrier, DMSO. (E)
Pretreatment with colchicine (10 μM), which inhibits microtubule polymeri-
zation, does not block folding: carrier, ethanol. The data for each inhibitor
are from >100 uptake events from three independent experiments with
BMDMs from different mice. Statistical comparisons were made using a χ2
test: ***P < 0.001; ****P < 0.0001; ns, not significant.
Fig. 3. PAMP–PRR interactions but not Syk1-CARD9 signaling promote hy-
phal folding. (A) Inactivation of Dectin-1 blocks folding of nonopsonized C.
albicans tup1Δ hyphae by BMDMs: wild-type (WT) BMDMs; Dectin-1 KO (n =
44), BMDMs from Dectin-1−/− mice (n = 111); unfolded cells (gray), hyphae
displaying moderate bending (obtuse angle; pale green), and hyphae dis-
playing (acute angle; dark green). (B) Folding of opsonized C. albicans tup1Δ
hyphae is attenuated in BMDMs from Dectin-1−/− mice (n = 98) compared
with WT BMDMs (n = 209). (C) The Dectin-1 blocking agent, laminarin, re-
duces folding of fixed tup1Δ hyphae by BMDMs from WT mice: n = 305
(+ laminarin); n = 337 (− laminarin). (D) Inactivation of CARD9 does not in-
hibit folding: WT (n = 59); CARD9 KO (n = 81). (E) Inactivation of MyD88
does not affect folding: MyD88 KO (n = 115) compared with WT (n = 113).
(F) Pretreatment of BMDMs with antibodies against the glucan binding
domain of CD11b (anti-CD11b) did not affect folding of fixed tup1Δ hyphae
compared with treatment with isotype controls: n = 122 (anti-CD11b) and
n = 107 (isotype control). (G) In contrast, pretreatment of BMDMs with an-
tibodies against CD18 (anti-CD18) reduced folding of the tup1Δ hyphae
compared with the isotype controls: n = 144 (anti-CD18) and n = 145 (iso-
type). (H) The Focal Adhesion Kinase inhibitor, PF573288 (10 μM), attenuated
folding of the tup1Δ hyphae; n = 60 (PF573288); n = 87 (DMSO carrier). The
data for each experiment are from three independent analyses with BMDMs
from different mice. Statistical comparisons were made using a χ2 test:
**P < 0.01; ***P < 0.001; ****P < 0.0001; ns, not significant.
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uptake of the C. albicans cells by wild-type macrophages, as
expected (45, 46). Analyses of those hyphae that were phagocy-
tosed revealed that laminarin inhibited hyphal folding (Fig. 3C).
These data indicate that the engagement of fungal β-glucan by
Dectin-1 enhances hyphal folding within the macrophage. This
reinforces the view that this PAMP–PRR interaction continues to
promote macrophage functionality after phagocytosis (47, 48).
We probed Dectin-1 signaling by assessing the contribution of
caspase recruitment domain–containing protein 9 (CARD9),
which functions downstream in this pathway (49, 50). Our
comparisons of BMDMs from CARD9−/− knockout and wild-
type mice revealed no loss of hyphal folding by the CARD9−/−
macrophages (Fig. 3D). Also, Dectin-1 inhibition did not block
folding completely (Fig. 3 A–C). Therefore, other PAMP–PRR
interactions may contribute to the phenomenon. We extended our
analysis to include Toll-like receptor (TLR) signaling by examin-
ing myeloid differentiation primary response 88 (MyD88) (51).
BMDMs from MyD88−/− mice displayed a similar hyphal folding
capacity to their wild-type controls (Fig. 3E). We conclude that
while PAMP–PRR interactions are required for fungal folding
(Fig. 3 A–C), downstream PRR signaling via CARD9 or MyD88 is
not (Fig. 3 D and E).
We examined the role of integrin in folding because it provides
an additional means by which immune cells can engage an external
target across a membrane (52, 53). Also, the β2-integrin, comple-
ment receptor 3 (CR3), is another type of β-glucan receptor (54)
that promotes macrophage responses in collaboration with Dectin-
1 (55). CD11b and CD18 are subunits of CR3. Therefore, we
pretreated macrophages with M1/70 anti-CD11b antibody to block
the β-glucan–specific domain of CD11b, and then quantified their
ability to fold tup1Δ hyphae. Blocking CD11b did not disrupt hy-
phal folding (Fig. 3F). However, antibody-mediated inhibition of
CD18, which compromises the functionality of all four members of
the β2-integrin group, significantly reduced folding (Fig. 3G)
without affecting phagocytosis (SI Appendix, Fig. S1C). To further
assess the role of this PRR in folding, we blocked the downstream
signaling component, focal adhesion kinase (FAK), using the in-
hibitor PF-573228 (56). PF-573228–treated macrophages phago-
cytosed tup1Δ hyphae as efficiently as the carrier-only control cells
(SI Appendix, Fig. S1D) but were less able to fold them (Fig. 3H).
Therefore, Dectin-1 and β2-integrin may collaborate to promote
folding.
Podosomes and Folding. How do phagosomal synapses promote
folding? Podosomes have been associated with functions such as
the mechanosensing of phagocytic targets and local topological
properties during tissue migration (57, 58), and podosomes have
been implicated in the early stages of phagosome formation (59).
Furthermore, integrin promotes the formation of podosome-like
structures during phagocytosis (58, 59), and it plays a role in
hyphal folding (Fig. 3G).
Vasodilator-stimulated phosphoprotein (VASP) regulates the
formation of contractile actomyosin bundles to generate me-
chanical tension in nonmuscle cells (60) and is essential for
podosome formation (61). Interestingly, VASP colocalized with
dynamic actin structures surrounding phagosomes that contain in-
ternalized C. albicans hyphae (Fig. 4A). VASP is regulated by
adenosine monophosphate–activated protein kinase (AMPK) (62).
Macrophages treated with the AMPK inhibitor KT5823 (63–65)
were less able to fold hyphae than control cells (Fig. 4B). Conversely,
macrophages exposed to the AMPK activator 5-Aminoimidazole-4-
carboxamide ribonucleotide (AICAR) (63–65) displayed enhanced
folding compared with control macrophages (Fig. 4C). Taken to-
gether, these observations suggest that VASP activation promotes
the hyphal folding.
We investigated whether other components of focal adhesions
and podosomes are associated with hypha-containing phagosomes
by immunofluorescence microscopy. Talin, paxillin, and vinculin
were observed at macrophage periphery in focal adhesions and
podosomes, as described previously (66, 67). Significantly, we also
observed these proteins internally, surrounding phagosomes con-
taining C. albicans hyphae (Fig. 4D and SI Appendix, Fig. S2),
closely associated with actin bundles surrounding internalized hy-
phae (Fig. 4E). We also observed Dectin-1 on hypha-containing
phagosomes (Fig. 4F and SI Appendix, Fig. S3). Calpastatin inhibits
calpain-mediated turnover of podosomes (68). As expected (68),
calpastatin reduced macrophage motility slightly (Fig. 5 A and B).
Significantly, calpastatin also inhibited hyphal folding (Fig. 5C).
Taken together, these observations suggest that podosome-like
structures may contribute to hyphal folding.
Migratory Activity and Folding Capacity. Calpastatin affects cell mo-
tility as well as hyphal folding (Fig. 5 A and B). Also, perturbation
of cytoskeletal functionality attenuates folding (Fig. 2). Therefore,
we investigated the relationship between cell motility and folding
by interfering with motility in other ways.
The migratory capacity of macrophages depends on their acti-
vation status (69). Therefore, human monocyte–derived macro-
phages were used to generate M0, M1, or M2 cells. These three
macrophage subsets were then exposed to tup1Δ hyphae, and their
behaviors were then examined by live-cell imaging. The M1 cells
were less motile than the M0 controls and displayed less folding
(Fig. 5 D–F). Conversely, the M2 macrophages displayed in-
creased motility and enhanced folding.
Extracellular matrix components enhance the motility of migra-
tory cells (70–72). Therefore, human monocyte–derived macro-
phages were plated onto plastic or plastic coated with fibronectin.
Macrophages adhered to these substrata were fed tup1Δ hyphae,
and their folding capacity and motility examined by live imaging.
The fibronectin-coated surface increased the folding capacity of
BMDMs as well as their motility (Fig. 5 G and H).
These data suggest that hyphal folding is related to the mi-
gratory capacity of macrophages. However, folding is not entirely
governed by motility because Dectin-1−/− macrophages displayed
slightly increased motilities (SI Appendix, Fig. S4) but reduced
hyphal folding (Fig. 3 A and B).
Discussion
Lymphocytes invoke actin polarization and microtubule networks
during their mechanical delivery of cargo to target cells (41, 73),
and it is well known that phagocytes employ actin foci during their
engulfment of targets (16, 22, 57, 59). Our demonstration that
macrophages can fold fungal hyphae suggests that they are able to
exert physical force upon internalized targets, postphagocytosis.
This folding appears to be a general phenomenon executed by a
range of phagocytic cell types and on evolutionarily diverse
fungal targets.
Our data provide initial insights into the mechanics of hyphal
folding. Dectin-1 and β2-integrin individually promote but are not
essential for folding, which suggests that these PRRs may collab-
orate or that other factors may contribute to the process. Other
C-type lectin receptors that recognize mannans or chitin may play a
role in this process, such as Dectin-2, mannose receptor, or Mincle,
for example. Folding is not dependent on downstream CARD9
signaling from C-type lectin receptors or MyD88 signaling from
TLRs. This might imply that the formation of PAMP–PRR com-
plexes, rather than downstream signaling via these pathways, may
be critical for hyphal folding. These complexes may anchor the
hypha to the folding apparatus, which are located in the phag-
osome and cytoplasm, respectively.
The folding apparatus appears to require dynamic cytoskeletal
remodelling of actin and myosin II, rather than microtubule
functionality. Also, the folding capacity of macrophages appears to
be related to their motility, suggesting that hyphal folding may
exploit forces generated by the cytoskeletal network as it drives cell
migration. The involvement of β2-integrin and VASP signaling,
4 of 8 | PNAS Bain et al.



























together with the colocalization of the adhesion components talin,
paxillin, and vinculin at the surface of hypha-containing phag-
osomes, is consistent with the idea that podosome-like structures
may link the PAMP–PRR anchor to the cytoskeleton, thereby
permitting the transmission of this force from the cytoskeleton to
the fungal hypha.
Hyphal folding damages the hypha and attenuates its growth.
Therefore, we suggest that hyphal folding represents an addi-
tional weapon in the armory of the phagocyte, alongside reactive
chemical species, antimicrobial peptides, and enzymes, for ex-
ample. When combined with these other weapons, hyphal fold-
ing might help to tip the balance in favor of the phagocyte during
antifungal immunity. The phagocytosis of hyphae is not dependent
on folding. Nevertheless, by assisting the complete uptake of some
long filaments, hyphal folding presumably reduces the likelihood of
inappropriate immune activation via “frustrated” phagocytosis by
macrophages (33), for example. While we have focused on the
folding of fungal hyphae, we note that phagocytes may exert anal-
ogous forces upon other forms of cargo to promote their clearance.
Materials and Methods
Fungal Strains. The C. albicans clinical isolate SC5314 (74) and the C. albicans
tup1Δ null mutant CRC003 (23) were used throughout. These were grown in
YPD (2% dextrose, 2% mycological peptone, and 1% yeast extract) at 30 °C
overnight before examining their interactions with macrophages in Roswell
Fig. 4. Podosome components associated with phagocytosed hyphae. (A) VASP (anti-VASP antibody, green) colocalizes with actin (rhodamine phalloidin,
red) on BMDM phagosomes containing live C. albicans SC5413 (Calcofluor White; CFW, blue). Cells were fixed after 4 h of C. albicans–BMDM interactions and
subjected to phase differential interference contrast (DIC) and fluorescence microscopy. (B) Pretreating BMDMs with KT5823 (0.1 μM), which reduces
phosphoVASP levels, decreases their folding of fixed tup1Δ hyphae (n = 160) compared with the ethyl acetate carrier control (n = 186): unfolded cells (gray);
hyphae displaying moderate bending (obtuse angle; pale green); hyphae displaying (acute angle; dark green). (C) Preincubating with AICAR (0.3 mM), which
increases phosphoVASP levels, enhances the ability of BMDMs to fold tup1Δ hyphae (n = 145) compared with the H2O2 carrier control (n = 139). The data for
each experiment are from three independent analyses with BMDMs from different mice. Statistical comparisons were made using a χ2 test: *P < 0.05; **P <
0.01. (D) Podosomal components localize with actin rings around phagosomes containing live C. albicans SC5314 hyphae. Three independent examples of this
colocalization are shown: phase DIC microscopy, fungal chitin (CFW, blue), BMDM actin (rhodamine phalloidin, red), talin (anti-talin antibody, green; Top),
paxillin (anti-paxillin antibody, green; Middle), and vinculin (anti-vinculin antibody, green; Lower). (E) A close-up showing juxtaposition of actin (rhodamine
phalloidin, red) and vinculin (anti-vinculin antibody, green) on a BMDM phagosome containing a C. albicans SC5314 hypha. (F) Colocalization of Dectin-1
(anti-Dectin-1, red) and talin (anti-talin antibody, green) on BMDM phagosomes containing C. albicans SC5314 hyphae (chitin stained with CFW, blue).
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Park Memorial Institute (RPMI)-1640 medium. For some experiments, fungal
cells were fixed in 50 mM Thimerosal (Sigma-Aldrich) overnight and then
washed thoroughly in phosphate-buffered saline (PBS).
Phagocyte Preparation. J774.1 and RAW264.7 macrophages were cultured at
37 °C with 5% CO2 using Dulbecco’s Modified Eagle Medium (DMEM) sup-
plemented with 10% (volume/volume) heat-inactivated fetal calf serum
(FCS: Sigma) and 200 U/mL penicillin/streptomycin (Sigma). Thioglycolate-
elicited peritoneal macrophages [thio-macs (16)] and BMDMs (75) were
generated as described previously. For some experiments, BMDMs were
prepared from knockout mice lacking CARD9, Dectin-1, or MyD88 (43, 49,
76). BMDMs were treated at the following final concentrations in the
specified carriers: 5 μM cytochalasin D in dimethyl sulfoxide (DMSO), 1 μM
latruncilin A in DMSO, 20 μM blebbistatin in DMSO, 10 μM colchicine in
EtOH, 100 μg/mL laminarin in RPMI, anti-Cd11b or isotype (abcam 8878)
added at 33 μg/mL, anti-CD18 or isotype (abcam 119830) added at 33 μg/mL,
10 μM PF573228 in DMSO, 1 μM KT5823 in ethyl acetate, 0.3 mM AICAR in
H2O, and 50 μM calpastatin in H2O.
Human monocyte–derived macrophages were prepared from the blood of
healthy volunteers using density centrifugation followed by magnetic-
activated cell sorting of CD14+ populations (Miltenyi Biotech) and cultured
in DMEM containing 10% autologous human serum (77). For experiments with
differentially activated monocytes, cells were left untreated until day 7 to
generate M0 cells. M1 cells were generated by treating M0 cells with 50 ng/mL
IFN-γ on day 5, then with 10 ng/mL lipopolysaccharide on day 6. M2 cells were
generated by exposing M0 cells to 10 ng/mL IL-4 on day 5 for 48 h. Monocytes
were analyzed on day 7. The monocytes were imaged on fibronectin-coated or
standard tissue culture plastic. Fibronectin coating was performed by adding
5 μg/cm2 fibronectin in water to imaging wells and allowing evaporation.
Visualization of Cell Components. To visualize exposure of fungal cell wall
components at fracture points of phagocytosed and folded filaments,
Fig. 5. Influencing podosomal functionality or cell motility affects fungal folding. (A) Pretreatment with calpastatin (50 μM), which inhibits podosome
turnover and function, decreases BMDMs motility as determined by tracking the movement of individual macrophages for 1 h: n = 30 per condition.
(B) Quantification of BMDM motility based on the tracking shown in (A). (C) Folding of fixed C. albicans tup1Δ hyphae was impaired in calpastatin-treated
BMDMs (50 μM, n = 193), compared with the carrier alone (H2O, n = 186): unfolded cells (gray); hyphae displaying moderate bending (obtuse angle; pale
green); hyphae displaying (acute angle; dark green). (D) Human monocyte–derived were either untreated (M0), activated with IFN-γ and lipopolysaccharide
(M1), or with IL-4 (M2) and then analyzed. Individual cells were tracked: n = 30. (E) The motility of these cells was then quantified. **P < 0.01; ***P < 0.001.
(F) The ability of these cells to fold C. albicans tup1Δ hyphae was also quantified: M0 (n = 152 uptake events); M1 (n = 104); M2 (n = 147). (G) Human
monocyte–derived macrophages were plated on standard or fibronectin-coated imaging dishes, combined with fixed tup1Δ hyphae, and imaged. Their
motility was assayed by tracking individual cells (n = 30 for each condition). (H) Their ability to fold the tup1Δ hyphae was also quantified: n = 278, uncoated
plates; n = 328, fibronectin-coated plates. The data for each experiment are from three independent analyses with macrophages from different mice or
human donors. Statistical comparisons of folding were made using a χ2 test, and statistical analyses of the motility datasets used the unpaired t test (B and G)
or ANOVA (GraphPad Prism).
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exposed mannan was stained with concanavalin A (ConA) conjugated to
Alexa Fluor 594 (Invitrogen), exposed chitin was stained with wheat germ
agglutinin (WGA) conjugated to Alexa Fluor 350, exposed β-glucan was
stained with Fc-Dectin-1 (78), and then goat F(ab′)2 antihuman IgG conju-
gated to Alexa Fluor 488. After coincubation of thio-macs and SC5314 for
4 h, macrophages were lysed with dH2O for 30 min, and fungal cells were
fixed in 4% paraformaldehyde for 45 min and then washed twice with PBS
and once with staining buffer (PBS containing 1% FCS and 0.5 mM
ethylenediaminetetraacetic acid [EDTA]). Staining was performed in two
sequential steps. First, cells were incubated with 1.0 μg/mL Fc-Dectin-1 in
staining buffer for 45 min on ice. Then cells were incubated with 50 μg/mL
WGA, 25 μg/mL ConA, and 1:200 Gt F(ab’) antihuman IgG in staining buffer
for 30 min on ice. Control cells were only stained with the secondary
antibody.
BMDM cellular components were visualized following phagocytosis of live
SC5314 or fixed tup1Δ filaments after specified time intervals, as required.
Cells were fixed with 2% paraformaldehyde for 10 min and then washed
thrice with PBS. Fungal chitin was visualized by Calcofluor White staining
(10 mg · mL−1 in dH2O for 20 min, or overnight if combined with primary
antibody). Fixed actin was stained using rhodamine phalloidin (Invitrogen) at
1:200 for 1 h, or overnight if combined with primary antibody. Immunofluo-
rescent staining was performed on fixed cells following permeabilization with
0.2% Triton-X 100. Key BMDM components were visualized by staining with
1:400 anti-VASP (Cell Signal Technologies 3132), 1:100 anti-talin (Abcam
71333), 1:100 anti-paxillin (Abcam 32084), or 1:250 anti-vinculin (Abcam
129002) in antibody buffer (PBS containing 1% FCS, 0.5 mM EDTA in PBS for
VASP, or 0.5% saponin and 5% goat serum for talin, paxillin, and vinculin)
overnight at 4 °C, then washed. Secondary antibody goat anti-rabbit Alexa
Fluor 488 was applied at 1:200 in antibody buffer for 1 h at room temperature.
Dectin-1 was visualized in fixed cells using 10 μg/mL of anti-Dectin-1 antibody
7G7 in 0.25% saponin, 1% bovine serum albumin, and 1% goat serum
(overnight, chilled). Goat anti-rat Alexa Fluor 594 secondary antibody was
applied at 1:200 for 1 h. Live actin was stained using SiRActin (Spirochrome) at
200 nM for 4 h prior to imaging.
Live Imaging of Fungal-Phagocyte Interactions. The folding of internalized
fungal cargowas quantified first by performing live imagingusing a PerkinElmer
UltraVIEW VoX Spinning Disk microscope (Nikon ×20/0.75 Plan Apo VC ob-
jective). Movies were acquired using Volocity software 6.4 (PerkinElmer),
collecting images at 2 min intervals for up to 6 h for wild-type cells and
for up to 4 h for tup1Δ cells. Some data were collected using a Zeiss
Celldiscoverer 7, capturing images with a ×20/0.95 Plan Apo objective. For
macrophages that had phagocytosed a fungal filament, the folding of the
hypha was categorised as “none” (no detectable bending or folding); “low”
(creating a curved hypha or an obtuse angle), or “high” (generating an
acute angle). Experiments were performed independently on multiple
occasions using innate immune cells from at least three mice or human
donors. Statistical analyses were performed using the χ2 test in
GraphPad Prism.
The motility of innate immune cells was measured first by selecting ran-
dom macrophages at frame 1, including non/phagocytosing and non/folding
macrophages. Volocity manual tracking was performed on the selected
macrophages by marking the central point of each macrophage with each
advancing frame for the first 60 min of the movie. Individual track steps were
combined (per condition) to determine mean velocity (μm/sec): n = 30 cells
for each condition; n = 3 independent experiments. Statistical comparisons
of two conditions were performed using an unpaired t test or χ2 test, as
specified, and using ANOVA for three or more conditions (GraphPad Prism).
Cellular localization was examined by capturing Z stack images (0.3 μm
step size) using a PerkinElmer UltraVIEW Vox spinning disk microscope using
a Nikon Plan Apo VC ×60/1.4 oil objective.
Growth of C. albicans hyphae during phagocytosis and folding was de-
termined by measuring hyphal extension rates with the line tool in Volocity.
Ethics Statement. Blood from healthy volunteers was collected with the in-
formed consent of these donors and according to local guidelines and reg-
ulations. Our full study protocol was approved by the College Ethics Review
Board of the University of Aberdeen (2016/8/1300).
Thio-macs were prepared from 10 to 14 wk old C57BL/6 female mice and
BMDMs from 8 wk old male C57BL/6, CARD9−/−, Dectin-1−/−, or MyD88−/− mice.
These mice were selected randomly, bred in house, and housed in stock cages
under specific pathogen-free conditions. They underwent no surgical proce-
dures prior to culling by cervical dislocation. All animal experimentation was
approved by the UK Home Office and by the University of Aberdeen Animal
Welfare and Ethical Review Body.
Data Availability. All study data are included in the article and/or supporting
information.
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